Parul, F.; Ratnani, T.; Subramani, S.; Bhatia, H.; Ashmawy, R.E.; Nair, N.; Manchanda, K.; Anyagwa, O.E.; Kaka, N.; Patel, N.;
et al. Anticoagulation in Patients with End-Stage Renal Disease: A Critical Review. Healthcare 2025, 13, 1373.
https://doi.org/10.3390/healthcare13121373
AMA Style
Parul F, Ratnani T, Subramani S, Bhatia H, Ashmawy RE, Nair N, Manchanda K, Anyagwa OE, Kaka N, Patel N,
et al. Anticoagulation in Patients with End-Stage Renal Disease: A Critical Review. Healthcare. 2025; 13(12):1373.
https://doi.org/10.3390/healthcare13121373
Chicago/Turabian Style
Parul, FNU, Tanya Ratnani, Sachin Subramani, Hitesh Bhatia, Rehab Emad Ashmawy, Nandini Nair, Kshitij Manchanda, Onyekachi Emmanuel Anyagwa, Nirja Kaka, Neil Patel,
and et al. 2025. "Anticoagulation in Patients with End-Stage Renal Disease: A Critical Review" Healthcare 13, no. 12: 1373.
https://doi.org/10.3390/healthcare13121373
APA Style
Parul, F., Ratnani, T., Subramani, S., Bhatia, H., Ashmawy, R. E., Nair, N., Manchanda, K., Anyagwa, O. E., Kaka, N., Patel, N., Sethi, Y., Kavarthapu, A., & Padda, I.
(2025). Anticoagulation in Patients with End-Stage Renal Disease: A Critical Review. Healthcare, 13(12), 1373.
https://doi.org/10.3390/healthcare13121373